John W. LaRocca
2018
In 2018, John W. LaRocca earned a total compensation of $4.2M as General Counsel and Assistant Secretary at Aerie Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $153,700 |
|---|---|
| Option Awards | $2,677,383 |
| Salary | $361,141 |
| Stock Awards | $975,600 |
| Other | $6,225 |
| Total | $4,174,049 |
LaRocca received $2.7M in option awards, accounting for 64% of the total pay in 2018.
LaRocca also received $153.7K in non-equity incentive plan, $361.1K in salary, $975.6K in stock awards and $6.2K in other compensation.
Rankings
In 2018, John W. LaRocca's compensation ranked 2,629th out of 14,244 executives tracked by ExecPay. In other words, LaRocca earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,629 out of 14,244 | 82nd |
Division Manufacturing | 972 out of 5,765 | 83rd |
Major group Chemicals And Allied Products | 331 out of 2,128 | 84th |
Industry group Drugs | 269 out of 1,817 | 85th |
Industry Biological Products, Except Diagnostic Substances | 54 out of 339 | 84th |
Source: SEC filing on April 10, 2019.
LaRocca's colleagues
We found four more compensation records of executives who worked with John W. LaRocca at Aerie Pharmaceuticals in 2018.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019